COVID-19 Diagnostics Market accounted US$ 8.3 billion by 2029 and is expected to register a CAGR of 6.1% during the forecasted period.


 The COVID-19 diagnostics market accounted for US$ 4.9 billion in 2020 and is estimated to be US$ 8.3 billion by 2029 and is anticipated to register a CAGR of 6.1%.

The report "Global COVID-19 Diagnostics Market, By Product (Instruments and Reagents & Kits), By Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, and Others), By Technology (Polymerase Chain Reaction (PCR), Antibody or Enzyme-Linked Immunosorbent Assay (ELISA), Serology, Portable or Point-of-Care (POC), and Others), By End-user (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2027”.

Key Highlights:

  • In April 2020, the FDA declared that U.S. Cotton has planned to develop polyester-based swabs in large quantities that can also be put to use in sample collection for coronavirus testing. These initiatives are projected to further expand the adoption rate of swabs at a profitable rate.
  • In April 2020, GeneFirst the U.K.-based firms, and Rapid Diagnostics in an agreement legalized a COVID-19 assay launched by the former company to be used on the Rapid’s Rapid Minilab RT-PCR Desktop Point of Care Platform. This agreement permitted the development of a POC test with an automatic sample-to-result workflow. Such initiatives are projected to propel the demand for point-of-care tests in the coming years.

Analyst View:

Growth in prevalence’s of coronavirus worldwide

Due to increasing number of cases infected by coronavirus globally, there is increase in need for developing diagnostic tests which is expected to propel the global market growth. In addition, for accurate and efficient COVID-19 diagnosis, clinicians requires an on-site or a portable diagnostic test for real-time management of patients in minimal time. This has led to stimulate the approval of Point-of-Care (POC) testing for diagnosis, mainly designed at decreasing the assay duration from hours to a few minutes. For instance, in March 2020, the Food and Drug Administration (FDA) delivered Emergency Use Authorization (EUA) to the first POC test-Xpert Xpress test developed by Cepheid-for COVID-19 diagnosis. Chembio and Abbott Diagnostics are among the leading market players working in the point-of-care marketplace.

Integration of novel technologies

Adoption of software solutions and novel technologies with COVID-19 testing is projected to create new avenues for market expansion. For example, the manufactures are involved in incorporating artificial intelligence (AI) algorithms in COVID-19 tests for efficient and rapid diagnosis. Moreover, Surgisphere Corporation, a U.S.-based firm, launched an AI-based rapid diagnostic tool for the detection of coronavirus in March 2020. This diagnostic tool involves 99.9% specificity and 93.7% sensitivity, supplementing accurate identification of virus and avoiding transmission of the infection.

Key Market Insights from the report:        

The global COVID-19 diagnostics market accounted for US$ 4.9 billion in 2020 and is estimated to be US$ 8.3 billion by 2029 and is anticipated to register a CAGR of 6.1%. The market report has been segmented on the basis of product, sample type, technology, end-user, and region.

  • By product, the reagents and kits segment is accounted to lead the COVID-19 diagnostics market as they are critical components in testing of coronavirus infection with a profit share of 72% in 2020. The WHO has announced nations to expand their diagnostics capacities, which is projected to drive the acceptance of reagents and kits at a large scale.
  • By sample type, the oropharyngeal and nasopharyngeal swabs segment is projected to estimate for the highest revenue share of 53% in 2020. Nasopharyngeal swabs are favored method for sample collection as recommended by the CDC. Whereas, in case of absence of nasal swabs, oropharyngeal swabs are also preferred.
  • By technology, the PCR segment is anticipated to lead the market in 2020 with a 45% revenue share. PCR is projected to lead owing to majority of the COVID-19 detection tests depending on Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for quantification of RNA in the samples of coronavirus patients.
  • By end-user, laboratories segment is accounted to register for the maximum revenue share of 40% in 2020. The laboratories are continuously expanding their testing capacities to meet the growing demand. Additionally, private laboratories are also directing toward coronavirus testing.
  • By region, Europe is likely to lead the target market for COVID-19 diagnostics with a share of 40% in 2020, owing to high awareness levels about the diagnosis, spread, and effective management of coronavirus infection

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4255

Competitive Landscape:

The prominent player operating in the global COVID-19 diagnostics market includes Abbott Diagnostics, Accelerate Diagnostics, Expedeon Ltd., Beckman Coulter Inc., Ador Diagnostics, Cepheid Inc., Akonni Biosystems Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, Lonza, and Fusion Genomics Corporation.

The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Osteoporosis Treatment Market is estimated to be US$ 17.68 billion by 2030 with a CAGR of 4.3% during the forecast period

Image
  The   Osteoporosis Treatment Market   accounted for US$ 11.60 billion in 2020 and is estimated to be US$ 17.68 billion by 2030 and is anticipated to register a CAGR of 4.3%. Osteoporosis is a condition in which body loses too much bone and there is an increase in bone weakness. The individual suffering from osteoporosis is more exposed to bone fractures. Hence, a proper treatment is required to cure and avoid the chances of complications. Osteoporosis, or thinning bones, can result in painful fractures. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Prevention and treatment include calcium and vitamin D, exercise, and osteoporosis medications. The report “ Global Osteoporosis Treatment Market By Drugs Type (Selective Estrogen Receptor Modulators (SERMs), Rank Ligand (RANKL) Inhibitor, Calcitonin, Hormone Therapy, Parathyroid Hormone-Related Protein (PTHrP) Analog, and Bisphosphonates (Risedrona
Read more

Hand Sanitizers Market is estimated to be US$ 2.70 billion by 2030 with a CAGR of 7.50% during the forecast period

Image
  Hand Sanitizers Market  accounted for US$ 1.31 billion in 2020 and is estimated to be US$ 2.70 billion by 2030 and is anticipated to register a CAGR of 7.50%. Hand sanitizer is an antiseptic solution, also known as a hand disinfectant, hand antiseptic, hand rub. It is a liquid or gel containing alcohol use as an alternative to soap and water. It is used to clean the hands and kill infection-causing microorganisms. The main difference between washing hands with soap and hand sanitizer is soap work to remove all types of germs from hands, while sanitizer acts as killing germs present on the skin. It is an alcohol-based hand sanitizer work to reduce the number of germs but it is less effective in removing harmful chemicals, such as pesticides and heavy metals like lead. The report " Global Hand Sanitizers Market by Type (Gel, Foam, and Spray), By Application (Restaurant, Hospital, School, Household, and Office Building,), and By Region (North America, Europe, Asia Pacific, Latin Am
Read more

Sternal Closure Systems Market is estimated to be US$ 3.79 Billion by 2020 with a CAGR of 5.6% during the forecast period 2030

Image
  Sternal Closure Systems   Market  accounted for US$ 2.3 million in 2020 and is estimated to be US$ 3.79 billion by 2030 and is anticipated to register a CAGR of 5.6%.        The Sternal Closure Systems are used in bilateral thoracosternotomy, median sternotomy and hemisternotomy. Median sternotomy has become popular in early 1960s and remains gold standard approach in cardiac procedures. Sternal Closure Systems are used in stabilization and fixation of fractures at anterior part of chest wall. Change in lifestyle, lack of exercise and unhealthy diet has become common cause of cardiovascular diseases. Newly developed technology in medical field in metropolitan cities has given rise to heart surgeries which has boosts the Sternal Closure Systems Market. As cardiac surgeries had become routine surgery, it is determined that annually around one million heart surgeries are performed worldwide. Rate of coronary heart diseases are high in United States of America. According to data publishe
Read more